At Pharmidex, we understand the critical role of general toxicology studies in drug development. We provide tailored support for small molecules and biologics, serving as an integral extension of your team. Our services cover general toxicology studies for discovery or development programs, with or without GxP regulatory compliance. We seamlessly integrate safety pharmacology protocols into these studies, offering a range of study types to meet your research goals.
Our MHRA and OLAW and AAALAC accredited toxicology department will help you with your preclinical and other early-stage product development needs to assure product safety and regulatory compliance.
Pharmidex will design and implement standard and customised bespoke preclinical discovery or regulatory toxicology studies in our HO, MHRA, OLAW and AAALAC accredited
in vivo toxicology facility.
+44 (0) 870 240 5978
For any enquires regarding our services please email [email protected]
Copyright © 2024 Pharmidex All rights reserved. Privacy Policy | Terms & Conditions